Episode 33 - Two Presidents with Prostate Cancer; Two Different Approaches to Treatment with Sylvie Beljanski & Dr. John Hall, PhD

Is there finally real hope for prostate cancer? The answer may lie in science you're not being told about.

In this compelling episode of The Beljanski Cancer Talk Show, Victor Dwyer sits down with two pioneers in integrative cancer care:
🔹 Sylvie Beljanski, Founder of The Beljanski Foundation
🔹 Dr. John Hall, Research Director at The Beljanski Foundation

Together, they pull back the curtain on groundbreaking research into prostate cancer stem cells—and why these discoveries are critical to saving lives right now.

You’ll learn:
✅ Why stem cells—not tumors—may be the real root of prostate cancer
✅ The surprising contrast between President Joe Biden’s and President François Mitterrand’s prostate cancer treatments
✅ How integrative medicine and natural solutions are reshaping the future of prostate health
✅ The science behind the Beljanski Extracts and what sets them apart
✅ Why transparency in modern medicine isn’t just important—it’s urgent

Whether you're a patient, a caregiver, or simply someone who values truth in health, this episode delivers life-changing insight you won’t hear from the mainstream.

👉 WATCH NOW and take your power back: https://www.beljanski.org/beljanski-cancer-talk-show/episode-33-two-presidents-with-prostate-cancer-two-different-approaches-to-treatment-with-sylvie-beljanski-dr-john-hall-phd/
🧠 Share this episode to help someone else see the bigger picture.

📌 LEARN MORE
🎧 Catch all episodes: https://www.beljanski.org/podcast 
🌿 Explore the science: https://www.beljanski.org 
📩 Subscribe for updates: https://www.beljanski.org/newsletter 

Hey there! If you've been getting value from our podcast, we’d be so grateful if you could take a moment to leave a review on Apple Podcasts or Spotify. Your support helps us reach more people, and it truly means the world. Thanks so much for taking the time—it really makes a difference!

==================

Want to stay in the loop? Sign up and grab a FREE chapter of Sylvie’s eBook! 👉 https://www.beljanski.org/podcast/

To help support cancer research, head over to https://beljanski.org and learn more.

Grab the book and support The Beljanski Foundation! Get it here: https://www.beljanski.org/book (Use code EP1 at checkout for FREE shipping)

Stay connected and follow us for the latest updates: https://linktr.ee/thebeljanskifoundation

Chapters

• 1:02 Introduction & What You’ll Learn
• 2:24 Meet Sylvie Beljanski & Dr. John Hall
• 3:50 Prostate Cancer: Biden vs. Mitterrand
• 9:01 Dr. Mirko Beljanski’s Legacy
• 13:06 Integrative VS Conventional Medicine
• 20:26 The Truth About Beljanski Extracts
• 26:06 What the Research Says
• 30:05 Public Health Transparency
• 31:33 Final Takeaways + What You Can Do

Transcript

Two Presidents with Prostate Cancer; Two Different Approaches to Treatment
with Sylvie Beljanski & Dr. John Hall, PhD

Introduction and Episode Overview

Sylvie Beljanski: There is nothing that can be done. The best is to give him some morphine and prepare the country for early elections. The surgeon had said the cancer has spread everywhere.

Victor Dwyer: Hey, everyone! Welcome to The Beljanski Cancer Talk Show. Today's episode features a powerful and timely discussion with two incredible guests, Sylvie Beljanski, Founder of The Beljanski Foundation and Dr. John Hall, Research Director of The Beljanski Foundation. Together we'll dive into critical updates on prostate cancer research, including the groundbreaking work on prostate cancer stem cells, and why fundraising for this research has never been more urgent.

They'll also reflect on President Joe Biden's recent prostate cancer diagnosis, a national reminder of how widespread and serious this disease truly is, and how it underscores the need for integrative approaches and early intervention.

Get ready for an eye-opening discussion with Sylvie Beki and Dr. John Hall, one that could transform how we think about prostate health and healing.

Meet the Guests: Sylvie Beljanski and Dr. John Hall

Victor Dwyer: Sylvie and John, it's always so good to have you guys back on the show. We love having you here. And the one thing I wanted to ask Sylvie, for the people that don't know you yet, or maybe the new people that have come to the podcast for the first time, please, Sylvie, introduce yourself, who you are and a little intro of what you're doing here. 

Sylvie Beljanski: So, my name is Silvie Beljanski. I am the Founder of The Beljanski Foundation, the 501(c)(3) incorporated in New York since 1999. And I am also the President and Founder of Maison Beljanski, a company selling dietary supplements.

We are in Manhattan, in New York, on the Midtown East side, a nice little shop and I love to speak about everything we are doing at The Beljanski Foundation. That's really my passion. 

Victor Dwyer: Yeah. Yeah. We see that. We see that in you. And Dr. John Hall, please tell a little intro of who you are and what you're doing here.

Dr. John Hall, PhD: Yes. My name is Dr. John Hall and I'm the Director of Research at The Beljanski Foundation, and I've worked in that role for some years now. And, fortunately, we have generated a lot of high quality research, lots of publications focused on the activity, the mechanism, and the before unknown possibilities of the Beljanski, plant extracts, primarily anti-cancer effects, what we’re talking about today?

Comparing Presidential Prostate Cancer Treatments

Victor Dwyer: Great. Dr. Hall, what are the key differences between President Biden and President Mitterrand handling their prostate cancer diagnosis?

Dr. John Hall, PhD: Let me just start by referring to the similarities, which are important here. They're both older men when they were diagnosed, some time ago for Mitterrand, but very recently for Biden, President Biden, and they’re advanced cancers in both cases with metastatic disease, primarily the bone. This is a common occurrence meaning that prostate cancer isn't that common in men. It's 1 out of 8 overall. But as men age, the occurrence becomes more frequent and it's often diagnosed late, as are many cancers because there aren't that many symptoms.

By the time it is diagnosed, it can have spread. And that's true in both of these cases. Let me go on to say there's a fundamental difference in how the treatments for the two presidents were handled in the case, so far as we know, I have to add that. But I think both men were in the stage and went through traditional treatments.

That was true for Mitterrand and it appears to be what Biden is doing, but Mitterrand had a wonderful advantage. He worked with a doctor who was familiar with Mirko Beljanski’s research and the anti-cancer plant extracts, and he was in a position to take advantage of those extracts. And this had a significant improvement of his prognosis, gave him additional time, additional quality of life. So that's the difference. The main difference. 

Victor Dwyer: So, basically what I'm hearing is one took the very traditional approach of using only conventional medicine, and where Mitterrand used more natural and holistic healing methods which was like better.

Dr. John Hall, PhD: Yes, you could say that Mitterrand was involved with overall a holistic approach, an integrative approach 'cause he took advantage of whatever the traditional medicines the chemo and radiation could do. Plus he ended up taking the Beljanski extracts, which were very successful.

Sylvie Beljanski: Yeah. For those who, who don't know who Mitterrand was because it's in the past. François Mitterrand was a French president from 1981 to 1995.

So, he served two terms, were seven years at the time. And just president Biden, there was no way, officially that, to a knowledge that a president could be sick and any fear of disease was kept secret. And suddenly, whew surprise, the president has advanced prostate cancer.

So, when that became public for Mitterrand, that was the beginning of his second term, the beginning of the 90s. Of course, society had changed a lot. There was no social media at the time. Yes. No social media.

It was only the officials, what we call today, the legacy press, who was reporting about how the president was doing only those few chosen journalist who had access to the French White House who were allowed to report. There was a kind of agreement between the press and the, and the power, and it was kept secret that Mitterrand was, was very sick.

When my father was made aware of the situation, Mitterrand already had surgery. The surgeon had said the cancer has spread everywhere, there is nothing that can be done with, obviously very much in pain. The best is to put it, give him some morphine and prepare the country for early elections.

Victor Dwyer: Wow.

Sylvie Beljanski: So it, it was more advanced than we have ever seen Biden, actually. 

Victor Dwyer: Yeah. And it's pretty amazing. One thing that you even had a president take your supplements and take that natural holistic approach. That's a pretty big accomplishment, like in my opinion, like, for a president to actually take something that you guys produces.

Sylvie Beljanski: Indeed. I think Mitterrand was so far advanced that the surgeon said there is nothing that can be done for this guy. The conventional medicine is not going to be able to help him. We cannot do anything for this cancer. It's too far gone. But it's a French story, so it was a 'ménage à trois', and the mistress who was also living with a wife and the president in the French White House knew about a good doctor who had good results with a doctor, was using my father's products. And that's how this doctor started to be invited to the French White House.

See Mitterrand and recommend those products that indeed have made a huge difference because he was not taking anything else except morphine. So, there was no competition actually with any other treatment because he did not receive any conventional treatment. 

The Legacy of Dr. Mirko Beljanski

Victor Dwyer: Yeah. I want to dive in into who was Dr. Mirko Beljanski, and what role did his natural extracts play in Mitterrand's reported recovery? I know we talked about it a little bit, but is there any deeper dive that you wanna take there of how you wanna approach it?

Sylvie Beljanski: Yeah, I can explain who was, of course, my father, my late father was, he was a scientist at the Pasteur.

He made his entire career at the Pasteur Institute and the CNAS, which is a French equivalent of NIH. He was one of the first scientists to look at the environment as a cause to cancer, but also wonder how the environment is affecting our DNA. He come up with this difference between cancer DNA, healthy DNA, where the two strands of the cancer DNA are stretched and open compared to  healthy DNA.

He looked also for the, in the, to the environment to find natural compounds that would do exactly the opposite of environmental toxins that would recognize those big destabilized DNA of cancer cells and prevents their duplication.

John, do you want to add more about the way those products are acting?

Dr. John Hall, PhD: No, I think that's a good summary. The emphasis is on research. Beljanski found a way to measure the activity of an anti-cancer compound, as I call the Oncotest, just as Sylvie said, find compounds, natural extracts in this case, that stop the replication of DNA, specifically cancer cell DNA, but having very little to no effect on healthy cell DNA.

So, these are test tube experiments in the laboratory which gave him a reason to pursue a couple of plant extracts called Pao Pereira and Rauwolfia Vomitoria. And he went on after these initial discoveries to study the activity of these extracts in cells, which is what we do in labs with cancer compounds and many other things.

First cells, invitro, and then in animals. And he showed very good results in both contexts and that's what we inherited. I can go on, I'll talk later about what the foundation has done, but we're just, it's a research organization that has continued his research and it's been very successful.

Victor Dwyer: And one thing I wanted to add on is in what ways, Sylvie, did Mitterrand's health appear to improve after the beginning of the Beljanski protocol according to the observers of Mitterrand?

Sylvie Beljanski: Yeah. So as I told you, there was no social media at the time, so the decay, the fact that the, the president was very ill did not appear that publicly because he was sheltered by the complacent and amicable press. But his public appearance had become more and more rare. There was reports that he had missed some big event or sent the Prime Minister to replace him. And very quickly, there was some questions.

People were questioning what happens with Mitterrand, why, where is he? Where is the president? But very quickly after he started to take the products, he started to appear again and he looked tired, but okay, I was present. And then in a matter of months, he started to look himself again and started to give speeches and to travel again.

And he was able to finish his second term, again, seven years. At the end of his second term, he was very alert and he looked in good condition. He improved very quickly over time, and that lasted for as long as he wanted because he chose, himself, to put an end to his life after he, he had left the French White House.

Victor Dwyer: That's amazing. 

Integrative Medicine vs. Conventional Treatments

Victor Dwyer: And this is for Sylvie and you John as well, like what is integrative medicine for the people that don't know what it is yet, and how did Mitterrand’s use of it differ from Biden's conventional approach? 

Dr. John Hall, PhD: Let me speak to that. I think integrative medicine really means anything that is not traditional or conventional.

And as I've already said, the important ingredient for effective alternative or holistic medicine is to have research behind it. That's really what makes it viable. The inclusion of this for Mitterrand, I think, was a lifesaver, as Sylvie has described. There are two factors there. Extension of life and quality of life during that extension.

We don't know much about President Biden's treatment, but it sounds like it's conventional. And ultimately, this podcast should be an invitation to President Biden and his doctors to consider alternatives. I think it's well worth pointing that out. Let me also say, and I should add, that the combination of mainstream or conventional therapies and alternative therapies in the form of the Beljanski extracts, it's also very successful.

So, it's not an either or situation. Integrative means bringing these two approaches together, and it's possible to do that, simultaneously, in the same treatment protocols at the same time. One other advantage of that is, as you may know, these conventional treatments are very often difficult for patients to take, to withstand.

They can be toxic, there're side effects, and some patients handle that better than others, but it's not a pretty picture in many cases, whereas the plant extracts that Beljanski developed do not have negative side effects. So, you're in a different world there, but when you bring those two worlds together, you can actually reduce the concentrations of the more toxic drugs, take advantage of their anti-cancer effect while having the non-toxic extract combine.

Ultimately, it's called a dose reduction effect on the mainstream therapy. You need less chemo drug. 

Sylvie Beljanski: Yeah, and I would like to add that The Beljanski Foundation has done extensively a number of research on prostate and prostate cancer that was done as a result of partnerships with Columbia University, mostly, and Nanjing University.

And the synergy of action with chemotherapies, including the one which is often used for prostate cancer, which is Docetaxel has been confirmed. And also, there was a publication studying the effectiveness of Pao Pereira on advanced prostate cancer cells which do not respond anymore to hormonal treatment, castration therapy which have been rumored to be used by Biden.

Victor Dwyer: Adding onto that, like, what are the problems with conventional treatments for prostate cancer and what are the side effects of it?

Ad: Prostabel®

Welcome to a new chapter in Men's Health. Prostabel® offers a natural boost for men over 50, concerned with maintaining their prostate health. The capsules are packed with 310 milligrams of Pao Pereira, and 60 milligrams of Rauwolfia Vomitoria, ensuring potent support for your prostate.

Experience broad spectrum support with safe and non-prescription ingredients, all backed by science. Plus, enjoy the added benefit of reduced nighttime bathroom visits, helping you achieve a more restful and uninterrupted sleep.

Discover real stories and transformative experiences. Visit our website to see what others are saying about Prostabel®.

Take charge of your wellbeing with confidence and feel better naturally. Discover Maison Beljanski. Sourced from nature. Perfected by science. Enjoy a 15% discount on your first purchase with code EP2. Prostabel®, where your health journey begins.

Integrative Medicine vs. Conventional Treatments (continuation)

Dr. John Hall, PhD: Well, there are many side effects which come along with the fact that most of these conventional treatments, and I'm talking about chemotherapy and radiotherapy, radiation treatments, are not selective. So, when they hit the body, they're going to kill the relatively rapidly dividing cells in a tumor, but they're also going to damage other cells in their body that happen to be rapidly dividing even if they're healthy.

Hence, the negative side effects. And that includes, wiping out the GI tract, compromising the immune system. Given these side effects and others in the body, losing your hair is the least of your problems, but that's also a common side effects that people suffer from.

I think it's been hard for the whole world to comprehend and accept the fact that you can have active but selective plant extracts that kill cancer cells and leave healthy cells unharmed. 

That's really the story here. That's the gift that we're working with the legacy of Beljanski that we have been continuing to study and develop.

Sylvie Beljanski: Yeah. And when it comes to hormonal treatment, also hormonal treatment testosterone is very often removed. Men get deprived chemically from their testosterone because testosterone is associated to fueling the cancer. But this is going to slow the natural process evolution of cancer. It’s not going to destroy cancer cells. So, at some point, the cancer will, nevertheless, continue to grow and then conventional treatment had just nothing to offer to those men.

There has been a publication research done at Columbia showing that even those cancer cells, which are extremely aggressive, which will not respond anymore to hormonal treatment, they will still be sensitive to Pao Pereira and Pao Pereira has different mechanism of action to address cancer cells ranging from NF-kappa B, which is a center for inflammation to apoptosis, to autophagy.

I really encourage people who are interested in the research to look at the website of The Beljanski Foundation, beljanski.org, and look at prostate, and they will find several publication on the topic. And again, the mechanism of action are several and cumulative, and it's really impressive considering that there is no side effects and no toxicity associated with those plant extracts because they are selective. They do recognize cancer cells. They stay away from healthy cells. They do not harm healthy cells. And that's really the beauty of the product. 

Victor Dwyer: Yeah. It really is like the difference between a shotgun approach, which hits everything and can kill everything versus a sniper approach, which is super targeted.

Dr. John Hall, PhD: That's well put. 

Sylvie Beljanski: So well said, yes!

Victor Dwyer: That's how a Texan describes it, with guns. 

The Science Behind Beljanski Extracts

Victor Dwyer: But yeah, my next question is what is Pao Pereira and Rauwolfia, and how are they believed to support prostate cancer and health cancer treatment. I know we just talked about it, but is there anything else you wanna add for those specific ingredients or supplements that you can take to possibly target it, and maybe go deeper into it, possibly? 

Sylvie Beljanski: Yeah. So, Pao Pereira comes from the bark of a tree from the Amazon rainforest, and we will create a, extract rich, which is natural and, and rich in, we know the active ingredient. And this has been extremely studied, and where Rauwolfia Vomitoria is coming from Africa. We used the root of the bark and this extract which is quite well known in Ayurveda medicine.

We do something different. We remove the reserpine, which could be toxic, and we have an extract which is devoid of reserpine, rich of alstonine, and is not associated with any toxicity. Again, just good to recognize also selectively cancer cells and not touching healthy cells. 

Victor Dwyer: John, is there anything else you wanted to add on to that or…

Dr. John Hall, PhD: I think that's a good explanation and I think it could be added that both of these extracts, interestingly, from a scientific standpoint, are structurally related. So, the active compounds are related to each other, which really helps make this whole story make sense because we're not yanking out compounds from nature that don't have anything to do with each other.

We're seeing similar effects, but not identical from the Pao extract and the Rauwolfie extract. But there's an underlying commonality in the structures which says, oh, that helps us understand how they're going to work in the cell, in the cancer cells.

Sylvie Beljanski: Yeah, and they have both shown in studies to inhibit inflammation, the modulation of NF-kappa B. They both have shown to show apoptosis of cancerous cells. Both have shown to be selective to cancer cells. They both have shown to be synergistic with a number of chemotherapies and, recently, they both have shown the ability to address stem cells. So, indeed they're extremely similar.

However, there are some differences between the two compounds. The Pao Pereira has also an antiviral benefit, which can also be interesting. And the Rauwolfia Vomitoria doesn't have any antiviral benefit, but it's very good at hormone regulation, can be helped with issues linked to fertility, hot flashes with menopause. There is a very good regulation in addition to the anticancer benefit. 

Victor Dwyer: So, technically you don't even need to have cancer to possibly take some of these supplements if you just wanted to take it for menopause or hormonal regulation or anything that you just described, correct? 

Sylvie Beljanski: Absolutely. Because, again, there is no side effect. 

Victor Dwyer: Yeah

Dr. John Hall, PhD: The take home there is also that we know, in the case of prostate, that these extracts are anti-inflammatory. And that means, specifically, that they are effective against the most common inflammation in men called BPH, Benign Prostatic Hyperplasia, which is a swelling of the prostate because of overgrowth of prostate cells, but it's not a cancer.

At the same time, that inflammatory condition is a forerunner of cancer. So a cancer is related to inflammation. And inflammation can, often, in many tissues, lead to a cancer. And both extracts are effective at that inflammatory step. And that means they're both effective for cancer prevention.

Sylvie Beljanski: Yeah. And again, we have research to show that for both compounds of Pao Pereira and Rauwolfia Vomitoria.

Victor Dwyer: Got it. Cool. Why is there renewed interest in Beljanski's plant-based treatments today, and what ongoing research supports their use of it? I know we talked about research and things like that. Is there anything else you wanna add on to that?

Sylvie Beljanski: I would not say there is a renewed interest. I think it has never went away, which is amazing considering that there is not a lot of publicity or effort. But between, I think, between my father, there's a time of Mitterrand in the 90s to nowadays, those products have always been around, always been available, and always in demand because it's a word of mouth. People know that they make a difference. And, thus, recommend that to their family and friends.

So, I would say the renewed, maybe the increased interest would come from the number of publications that have been obtained through the efforts of The Beljanski Foundation, and every time there is communication or around those publication service, of course, I mean, kind of renewed interest.

Dr. John Hall, PhD: Let me also contribute that I think with social media as well as our research there is a growing demand for alternatives. It's common knowledge that chemotherapy and radiation treatments are damaging to healthy tissues and cells, and I think people are more aware of that, more widely aware of it and are looking for alternatives.

And that's where we come up in the searches and the kind of investigations for alternatives. Once they find out that you don't have toxicity, you still get any cancer effect. It's, oh wow, renewed interest. 

Victor Dwyer: Got it

Dr. John Hall, PhD: Or new interest. 

Victor Dwyer: Yeah. 

Current Research and Future Directions

Victor Dwyer: And how does this, the research project at Kansas University Medical Center on prostate cancer stem cells relate to the Beljanski extracts, and what might this mean for the future of cancer treatment? 

Dr. John Hall, PhD: This relates to a fundamental discovery which dates back just over 20 years relating to the fundamental role that cancer stem cells are involved with cancer persistence and ultimately with metastasis and cancer spread. And it's now very well, not just modeled and thought about, but there's more and more evidence that the cancer stem cells really have a special role in the insidious part of cancer that it's hard to kill. It's evade, it evades treatments of all kinds. And so, a frontier in cancer research now is how to find treatments that actually target the cancer stem cells.

We believe cancer stem cells represent a small population of the cells in a tumor. So, not all cells in the tumor are the same genetically. There's real heterogeneity in there, but a small population are called stem cells, and that's because they have kept the property that healthy stem cells have to rapidly divide and to do so in an uninhibited fashion.

They could do it without cessation, and they can also resist the drug that are given. Many of them are drug resistant, cancer stem cells, and that means they can survive treatments. Even a treatment that shrinks the tumor still leaves behind some cancer stem cells. And over time, those can start, they wake up, meaning I should add, you get a remission if you get the tumor down and the symptoms that the cancer causes are reduced. But over time, the cancer stem cells, we think, are responsible for recurrence of the cancer.

And that's something most people are familiar with, that cancer comes back. And that's something that is caused by cancer stem cells and that recent research on prostate cancer. The new research we want to do will demonstrate and test, I say demonstrate 'cause I'm optimistic, but we need to test the effect of the extracts on prostate cancer stem cells specifically. And that's in the context of knowing already from previous work by our groups, that it works for pancreatic cancer stem cells, ovarian cancer stem cells, and breast cancer stem cells.

So, it's a combination of our research on cancer stem cells. But you can see the importance of it if these are the agents that actually cause recurrence of cancer and persistence and survival, and ultimately the death.

Sylvie Beljanski: The audience will be able to find the publication on pancreatic and ovarian cancer stem cells, which have been done in vitro and in vivo, again, on the website of the foundation, beljanski.org.

The breast cancer stem cell study is not finished, so the publication is not available yet, but the preliminary data is absolutely incredible. You have those mice which have been, two groups of mice have which have been injected with those very nasty breast cancer stem cells.

And you can see the group, control group is, all those metastasis are growing everywhere. And the group which has received the plant extracts, there is zero metastasis. Zero. I just, you look at that and you double take, how is it possible? So, we are extremely positive, extremely optimistic, and we look forward now to fund this research on the prostate cancer stem cells. Finish on breast, gets that published, and do the research on prostate. 'Cause even if we are very optimistic, you still need to do the research. You just cannot say it worked on one organ, let's assume and pray that it's going to work the same way for all organs. It generally does. So far, everything we have seen, it does, but we still need to do the research.

Victor Dwyer: Yeah. That's amazing. 

Public Perception and Transparency in Health

Victor Dwyer: And Sylvie, this question's for you. How did Mitterrand’s decision to keep his illness a secret influenced public perception? And how might that compare to today's expectation of transparency from public officials? Like how does this really influence the perception of keeping the illness a secret? And how has that influenced today and how people would see that? 

Sylvie Beljanski: So, I would say that at the time, because secret was well kept, it had little influence, actually, it didn't. Mitterrand succeeded to keep the secret because he did not disappear for very long from the public eye because he was able to put his hand on the Beljanski extracts quickly enough to reappear and appease all the suspicions that could have been raised because of his short absence. So, he succeeded. But again, it was the 90s, there was no social media. And we see that today, the expectations, the bar is much higher if the president is not there completely. If he doesn't seem well, everybody notices. And then you have all those social postings that start to go crazy and those videos that are posted and reposted and now, presidents cannot just, there is no place to hide.

Victor Dwyer: Yeah. True. 

Final Thoughts and Call to Action

Victor Dwyer: And out of everything that we've talked about, is there anything else that you want to add on to that conversation?

This could have been about Mitterrand, this could have been about Biden, conventional medicine. Is there anything else that you wanna make sure we talk about today? 

Sylvie Beljanski: I would like to stress that this is an amazing research program, those little plant extracts, extremely unique. I hear very often if it was working, we would hear about it. Well, you don't always hear about things because sometimes they get suppressed by the governments. That's what happened with the story of my father. We had to start all over again here in the states. But the publications are there, there are podcasts like this one where we are talking about it.

There are The Beljanski Cancer Conference where we are speaking about those things. I think that the argument is not valid anymore. The information is out there, but it takes some work to find it and we are here to help you. So also, I would like to say, this research is so unique, it's only there because people support it. And if you can support the foundation, please do so.

Victor Dwyer: Yeah. Is there any other books or events or any other materials that you wanna promote? I know you wanted to promote the research in there. Is there anything else you wanna make sure that we promote today before we end? 

Sylvie Beljanski: There is my book, ‘Winning The War On Cancer. The Epic Journey Towards A Natural Cure’ which tells all the story about what happened and how we started all over again and how Dr. Hall joined the organization and research programs that we started to do together at Columbia University on Prostate. That was our first research program. 

Victor Dwyer: That's amazing. Awesome! Sylvie and John, thank you so much for joining today. It was great to have you on again and covering all the intricacies between Mitterrand and President Biden. Thank you so much for joining, and audience, if you've listened up to this point, thank you so much for joining us on The Beljanski Cancer Talk Show, and we'll catch you next time. Thanks. 

Sylvie Beljanski: Thank you. 

Dr. John Hall, PhD: Thank you.